Amalgamated Bank’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60K Sell
11,414
-1,428
-11% -$4.85K ﹤0.01% 1621
2026
Q1
$23K Hold
12,842
﹤0.01% 1614
2025
Q4
$30K Sell
12,842
-948
-7% -$2.59K ﹤0.01% 1964
2025
Q3
$42K Hold
13,790
﹤0.01% 1893
2025
Q2
$38K Buy
+13,790
New +$45.3K ﹤0.01% 1904
2023
Q2
Sell
-53,685
Closed -$45K 3052
2023
Q1
$45K Sell
53,685
-8,104
-13% -$8.87K ﹤0.01% 2344
2022
Q4
$57K Hold
61,789
﹤0.01% 2360
2022
Q3
$105K Buy
61,789
+1,521
+3% +$3.98K ﹤0.01% 2130
2022
Q2
$129K Buy
+60,268
New +$160K ﹤0.01% 2066

Other funds holding CLOV

Amalgamated Bank's CLOV Position: Q2 2026 in Review

Amalgamated Bank reduced its Clover Health Investments (CLOV) stake by 11% in Q2 2026, selling an estimated $4.85K and leaving 11,414 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Amalgamated Bank first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. The position peaked at $129K in Q2 2022. 98 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Amalgamated Bank held 11,414 shares of Clover Health Investments worth $60K as of Q2 2026.
  • Amalgamated Bank sold 1,428 Clover Health Investments shares in Q2 2026, an estimated $4.85K.
  • Clover Health Investments made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1621 holding.
  • Amalgamated Bank first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
  • Amalgamated Bank's Clover Health Investments position peaked at $129K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.